tiprankstipranks
Advertisement
Advertisement

Glanbia advances €50m share buyback with latest Euronext Dublin purchases

Story Highlights
  • Glanbia bought and cancelled 9,762 shares on Euronext Dublin at an average €20.99 as part of its ongoing repurchase plan.
  • The buyback reduces shares in issue to about 242.3 million, signalling management confidence and enhancing shareholder value.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Glanbia advances €50m share buyback with latest Euronext Dublin purchases

Meet Samuel – Your Personal Investing Prophet

Glanbia ( (GLAPF) ) has issued an update.

Glanbia plc has continued its ongoing share buyback programme with the purchase and cancellation of 9,762 ordinary shares on Euronext Dublin on May 19, 2026, at a volume-weighted average price of €20.9945. The transactions were executed through broker J&E Davy as part of a previously announced plan to repurchase up to €50 million of shares by September 30, 2026.

Following this latest tranche of purchases and subsequent cancellation, Glanbia’s total ordinary shares in issue stand at 242,306,850, incrementally boosting earnings per share and signalling ongoing capital returns to shareholders. The continued execution of the buyback underlines management’s confidence in the company’s financial position and may support the stock’s valuation by reducing the free float over time.

More about Glanbia

Glanbia plc, which brands itself as the Better Nutrition company, operates in the nutrition sector with a focus on value-added dairy and performance nutrition products. The group targets health-conscious consumers and functional nutrition markets, positioning itself as a provider of specialised nutritional solutions across international markets.

Learn more about GLAPF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1